By Dr. Moxit Shah – Leading Endocrinologist in Ahmedabad PCOD (Polycystic Ovarian Disease) is one of the most common hormonal…
- April 29, 2026
Mounjaro for Weight Loss: A Modern, Evidence-Based Approach
By Dr. Moxit Shah, Endocrinologist Weight loss is no longer just about “eat less, move more.” As endocrinologists, we now…
By Dr. Moxit Shah, Endocrinologist, Ahmedabad “I’m eating less and exercising more, but the numbers on the scale just won’t…
- April 27, 2026
Mounjaro for Weight Loss: The “Dual-Action” Breakthrough-Dr Moxit Shah,Leading Endocrinologist in Ahmedabad
If you’ve been following the news on metabolic health lately, you’ve likely heard of Mounjaro (tirzepatide). While originally approved to…
- April 23, 2026
The Game-Changer: Understanding Weekly GLP-1 Injections for Diabetes-By Dr Moxit Shah Endocrinologist, Diabetes Expert in Ahmedabad
Managing Type 2 Diabetes has historically felt like a full-time job—constant monitoring, strict dieting, and for many, the dreaded daily…
Dr Moxit Shah DM Endocrinologist Introduction: Why “Management” Isn’t Enough Anymore Living with diabetes in a vibrant city like Ahmedabad…
For many living with diabetes, the snack aisle is a minefield. You’ve likely heard conflicting advice: “Dry fruits are natural…
In recent years, weekly injections have transformed the way we manage obesity. Unlike crash diets or short-term fixes, these medications…
- March 24, 2026
MOUNJARO OR OZEMPIC WHICH ONE IS BETTER FOR WEIGHT LOSS?
🔬 Core Difference Mounjaro (tirzepatide) → Dual action (GLP-1 + GIP) Ozempic (semaglutide) → Single action (GLP-1 only) 📊 Head-to-head…